What is ALS Phase II Ibudilast IBU-ALS-1201 Study?
CATEGORY:
TYPES:Generic: Ibudilast
This is a Phase II trial comparing the use of a medication known as ibudilast to placebo in 60 patients with ALS. This study is designed to measure the safety, efficacy, and tolerability of ibudilast when added to treatment with riluzole compared to placebo. NCT02238626
Save up to 80% off your prescriptions!
How do members experience ALS Phase II Ibudilast IBU-ALS-1201 Study?
Top 5 reported purposes & perceived effectiveness
| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Participate in clinical trial | 2 | 5 | |
| Amyotrophic lateral sclerosis | 1 | 3 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Rashes (redness, swelling) | 1 | |
| Stomach pain | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 1 | |
| Mild | 1 | |
| None | 3 |
Learn more about our community’s experience with ALS Phase II Ibudilast IBU-ALS-1201 Study
What are people saying about ALS Phase II Ibudilast IBU-ALS-1201 Study?
8
8
members have reported taking ALS Phase II Ibudilast IBU-ALS-1201 Study
Join the conversation and connect with people who have taken ALS Phase II Ibudilast IBU-ALS-1201 Study
Last updated: